Di Giacomo, Anna Maria
Valente, Monica
Cerase, Alfonso
Lofiego, Maria Fortunata
Piazzini, Francesca
Calabrò, Luana
Gambale, Elisabetta
Covre, Alessia
Maio, Michele http://orcid.org/0000-0002-0323-6321
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (ID 153732014)
Fondazione Italiana per la Ricerca sul Cancro (ID 21073)
Article History
Received: 7 August 2019
Accepted: 23 September 2019
First Online: 17 October 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Anna Maria Di Giacomo served as on Scientific or Advisory Boards of Bristol-Myers Squibb, Incyte, Glaxo-Smith Kline, Pierre Fabre;Monica Valente has not conflict of interest to declare;Alfonso Cerase has no conflict of interest to declare;Maria Fortunata Lofiego has not conflict of interest to declare;Francesca Piazzini has not conflict of interest to declare;Luana Calabrò served as on Scientific or Advisory Boards of Bristol-Myers Squibb;Elisabetta Gambale has not conflict of interest to declare;Alessia Covre has not conflict of interest to declare;Michele Maio served as on Scientific or Advisory Boards of Bristol-Myers Squibb, Roche-Genentech, Astrazeneca-MedImmune, Merck Sharp &Dohme and Glaxo-Smith Kline.